- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Invivyd Inc (IVVD)
Invivyd Inc stock price live, this page displays NASDAQ IVVD stock exchange data. View the IVVD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Invivyd Inc real time stock price chart below.
What Is the Invivyd Inc Stock Price Today?
The Invivyd Inc stock price today is 0.798.
What Is the Stock Symbol for Invivyd Inc?
The stock symbol for Invivyd Inc is ""IVVD.""
What Stock Exchange Does Invivyd Inc Trade On?
Invivyd Inc is listed and trades on the NASDAQ stock exchange.
Is Invivyd Inc a Good Stock to Buy?
Determining whether Invivyd Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IVVD quote. (ISIN: US00534A1025)
What Is the Invivyd Inc Stock Price Today?
The Invivyd Inc stock price today is 0.798.
What Is the Stock Symbol for Invivyd Inc?
The stock symbol for Invivyd Inc is ""IVVD.""
What Stock Exchange Does Invivyd Inc Trade On?
Invivyd Inc is listed and trades on the NASDAQ stock exchange.
Is Invivyd Inc a Good Stock to Buy?
Determining whether Invivyd Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IVVD quote. (ISIN: US00534A1025)
NASDAQ
Currency in USD
0.798
+0.044(+5.84%)
Closed·
After Hours
0.799+0.001(+0.14%)
·
Fair Value
An estimate of a Invivyd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.720
0.800
52 wk Range
0.355
2.740
IVVD Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 9 days
1/2
Fair Value
An estimate of a Invivyd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.7200.800
52 wk Range
0.3552.740
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IVVD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Invivyd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
4.933
Upside
+518.21%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Invivyd Inc Company Profile
Invivyd, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company’s pipeline includes PEMGARDA (pemivibart) injection, a half-life extended investigational monoclonal antibody (mAb) for the prevention of COVID-19 in adults and adolescents; VYD2311, an mAb candidate, which is in preclinical studies for the prevention or treatment of COVID-19; and Adintrevimab that is in phase 2/3 clinical trials for the prevention and treatment of COVID-19. It also has discovery stage candidates for the prevention of seasonal influenza and COVID-19. The company has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. The company was formerly known as Adagio Therapeutics, Inc. and changed its name to Invivyd, Inc. in September 2022. Invivyd, Inc. was incorporated in 2020 and is headquartered in Waltham, Massachusetts.
Invivyd Inc Earnings Call Summary for Q1/2025
- Q1 2025 revenue: $11.3M from PEMGARDA; EPS and revenue miss forecasts; stock drops 17.61% to $0.689
- Operating expenses cut 15% QoQ; company aims for profitability by mid-2025; cash position at $48M
- Sales force internalized, PEMGARDA availability expanded to 880 sites; transition disrupted sales
- New molecule VYD2311 in clinical development; company projects EPS of $0.01 for Q2 and $0.04 for Q3 2025
- Analysts forecast 6.22% revenue growth for FY2025; company expected to achieve profitability this year
Last Updated: 15/05/2025, 14:38
Read Full TranscriptCompare IVVD to Peers and Sector
Metrics to compare | IVVD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIVVDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.7x | −2.0x | −0.5x | |
PEG Ratio | −0.02 | −0.02 | 0.00 | |
Price/Book | 1.8x | 1.5x | 2.6x | |
Price / LTM Sales | 2.6x | 9.5x | 3.3x | |
Upside (Analyst Target) | - | 250.0% | 43.4% | |
Fair Value Upside | Unlock | 18.7% | 7.1% | Unlock |
Analyst Ratings
2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 4.933
(+518.21% Upside)
Earnings
Latest Release
May 15, 2025
EPS / Forecast
-0.14 / -0.02
Revenue / Forecast
11.30M / 36.89M
People Also Watch
FAQ
What Stock Exchange Does Invivyd Trade On?
Invivyd is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Invivyd?
The stock symbol for Invivyd is "IVVD."
What Is the Invivyd Market Cap?
As of today, Invivyd market cap is 95.72M.
What Is Invivyd's Earnings Per Share (TTM)?
The Invivyd EPS (TTM) is -1.19.
When Is the Next Invivyd Earnings Date?
Invivyd will release its next earnings report on 18 Aug 2025.
From a Technical Analysis Perspective, Is IVVD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Invivyd Stock Split?
Invivyd has split 0 times.
How Many Employees Does Invivyd Have?
Invivyd has 100 employees.
What is the current trading status of Invivyd (IVVD)?
As of 10 Aug 2025, Invivyd (IVVD) is trading at a price of 0.80, with a previous close of 0.75. The stock has fluctuated within a day range of 0.72 to 0.80, while its 52-week range spans from 0.36 to 2.74.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.